Ipsen Group - Company & Market Research Reports

Home /
Companies /
Ipsen Group

Ipsen is a global specialty-driven pharmaceutical group committed to discovering new solutions for targeted debilitating diseases. The company offers drugs in urology – oncology, endocrinology, neurology, gastroenterology, cognitive disorders, rheumatology, and cardiovascular areas. Its products include Decapeptyl, Hexvix, Somatuline, NutropinAq and Dysport. The company was founded in 1929 and is headquartered in Boulogne-Billancourt, France. Ipsen S.A. is a subsidiary of Mayroy S.A.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 83
Central Nervous System Drugs 66
Endocrine and Metabolic Disorders Drugs 50
Infusions and Injectables 33
Musculoskeletal Disorders Drugs 27
Surgical Procedures 21
Pharmaceuticals 20
Drug Discovery 16
Biopharmaceuticals 15
Prostate Cancer Drugs 13
Drug Delivery 13
Liver Cancer Drugs 10
Women's Health 10
Clinical Trials 10
Dermatology 10
Oncology 10
Neurology 9
Pancreatic Cancer Drugs 9
Medical Devices 8
Thyroid Cancer Drugs 8
Biotechnology 7
Lung Cancer Drugs 7
Healthcare Services 6
Breast Cancer Drugs 6
Genomics 6
Diagnostics 6
Gastrointestinal Drugs 6
Liver and Kidney Disorders Drugs 6
Company Reports 5
Immune Disorders Drugs 5
Kidney Cancer Drugs 5
Dermatological Drugs 5
Urology and Nephrology 4
Enzymes 4
Sexual and Reproductive Health Drugs 4
Therapeutic Area 3
Drugs by Therapeutic Area 3
Cardiovascular Drugs 3
Ovarian Cancer Drugs 3
Colon Cancer Drugs 3
Bladder Cancer Drugs 3
Managed Care 3
Over the Counter (OTC) Drugs 3
Urological Disorders Drugs 3
Optical Disorders Drugs 2
Lymphoma Drugs 2
In Vitro Diagnostics 2
Needles and Syringes 2
Hematology 2
Surgical Devices 2
Hematological Drugs 2
Biosimilars and Biosuperiors 2
Laboratory Equipment 2
Pediatrics 2
Gastroenterology 2
Pharmaceutical Intermediates 1
Allergy and Immunology 1
Infectious Diseases Drugs 1
Leukemia Drugs 1
Cervical Cancer Drugs 1
Brain Cancer Drugs 1
Point-of-Care Diagnostics 1
Infectious Disease Testing 1
Analgesics 1
Healthcare 1
Transdermal and Transmucosal Drug Delivery 1
Nuclear Medicine and Radiopharmacology 1
Skin Cancer Drugs 1
Anti-Obesity Drugs 1
Intensive Care and Emergency Medicine 1
Endocrinology 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

448 Results (Page 8 of 23)
- Relevance
  Sort by

Acromegaly Treatment Market - Global Forecast 2025-2032

 Report
October 2025
189 Pages
Global

From

€3128EUR$3,545USD£2,739GBP

€3475EUR$3,939USD£3,043GBP

Botox Injection Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
April 2023
71 Pages
Global

From

€3500EUR$4,250USD£3,172GBP

Neuroendocrine Tumors Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
157 Pages
Global

From

€1765EUR$2,000USD£1,545GBP

Controlled Substance Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3961EUR$4,490USD£3,469GBP

The Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - Cancer Edition - The Views of 520 Cancer Patient Groups

 Report
June 2024
64 Pages
Global

€9692EUR$11,370USD£8,200GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Ethical Pharmaceuticals Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3961EUR$4,490USD£3,469GBP

Melanocortin Receptor Agonist Drugs Market - Global Forecast 2025-2030

 Report
August 2025
184 Pages
Global

From

€3128EUR$3,545USD£2,739GBP

€3475EUR$3,939USD£3,043GBP

Congenital Hyperinsulinism Treatment Market - Global Forecast 2025-2032

 Report
October 2025
184 Pages
Global

From

€3128EUR$3,545USD£2,739GBP

€3475EUR$3,939USD£3,043GBP

The Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - USA Edition - The Views of 314 USA Patient Groups

 Report
May 2024
50 Pages
United States

€9692EUR$11,370USD£8,200GBP

Botulinum Toxin Market Size, Share, Trends and Forecast by Type, Application, End User, and Region, 2025-2033

 Report
October 2025
137 Pages
Global

From

€2249EUR$2,549USD£1,969GBP

€2646EUR$2,999USD£2,317GBP

Endometriosis Treatment Market Report and Forecast 2024-2032

 Report
July 2024
200 Pages
Global

From

€4366EUR$4,949USD£3,823GBP

Ewing Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
204 Pages
Global

From

€1765EUR$2,000USD£1,545GBP

Gallbladder Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
195 Pages
Global

From

€1765EUR$2,000USD£1,545GBP

Botulinum Toxin Filler Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
February 2023
89 Pages
Global

From

€3500EUR$4,250USD£3,172GBP

Interleukin Inhibitors Market Report 2025

 Report
April 2025
250 Pages
Global

From

€3961EUR$4,490USD£3,469GBP

Spasticity Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

 Report
May 2025
141 Pages
Global

From

€4191EUR$4,750USD£3,670GBP

Acromegaly Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

 Report
August 2022
168 Pages
Global

From

€2206EUR$2,500USD£1,931GBP

Botulinum Toxin Market - Forecasts from 2025 to 2030

 Report
March 2025
150 Pages
Global

From

€3485EUR$3,950USD£3,052GBP

Consumer Healthcare Market Report 2025

 Report
January 2025
200 Pages
Global

From

€3961EUR$4,490USD£3,469GBP

Facial Palsy Market - Global Forecast 2025-2032

 Report
November 2025
191 Pages
Global

From

€3128EUR$3,545USD£2,739GBP

€3475EUR$3,939USD£3,043GBP

448 Results (Page 8 of 23)
- 1
- 6
- 7
- 8
- 9
- 10

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.